Copper supplementation that reaches the brain reduces the signs and symptoms of Parkinson’s disease in a mouse model, a…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Changes in the bacterial communities in the gut and mouth are associated with cognitive impairment in people with Parkinson’s…
Casma Therapeutics said it will develop CSM-101 as a potential disease-modifying oral treatment for people with Parkinson’s disease and…
People in the presymptomatic stages of Parkinson’s disease have distinct patterns of stimulated immune responses relative to those with…
Switching actions and stopping movements involve two distinct cognitive motor processes, according to a study that combined computer modeling with…
A newly developed test was able to distinguish — with an accuracy of 95% — between individuals with and without…
Different types of exercise can have different effects on Parkinson’s disease, a study suggests. For instance, tai chi or…
Adults with Parkinson’s disease treated with the cell therapy bemdaneprocel spent less time in off periods, when symptoms were…
Performing cognitive tasks while walking may help distinguish between early Parkinson’s disease and multiple system atrophy (MSA), a…
Age-related declines in speech processes do not appear to contribute to the voice disturbances perceived by people with Parkinson’s…